phoneFree call from UK 0800 52 00 161 / Other countries: +34 960 451 185 personPrivate Area
phone

Free call

Request information
IVI IVI
MENUMENU
  • Treatments and services
        • ASSISTED REPRODUCTION
          • Artificial Insemination (AI)
          • In Vitro Fertilisation (IVF)
          • Egg donation
          • Genetic IVF (IVF + PGT-A)
        • PRESERVATION OF FERTILITY
          • Preservation of Fertility
        • IVI BABY PLAN
          • IVI Baby
        • TECHNIQUES
          • Vitrification of oocytes
          • EmbryoScope®
          • Semen Donation
          • ICSI
          • MACS
          • ROPA Method
          • Perfect Match 360º
        • TEST
          • Preimplantation Genetic Testing (PGT)
          • Non-Invasive Prenatal Tests
          • CGT: Compatibility Genetic Test
        • OUR DONORS
          • IVI: one of the world’s largest egg banks
        • Success rates
        • Prices
        • True Stories
        • The team
  • Clinics
        • Spain
          • A Coruña
          • Alicante
          • Almeria
          • Barcelona
          • Bilbao
          • Burgos
          • Cartagena
          • Castellon
          • Girona
          • Ibiza
          • Las Palmas
          • Lleida
          • Madrid – Alcorcón
          • Madrid – Aravaca
          • Málaga
          • Mallorca - Manacor
          • Mallorca - Palma
          • Murcia
          • Pamplona
          • Salamanca
          • San Sebastián
          • Santander
          • Sevilla
          • Tenerife
          • Valencia
          • Valladolid
          • Vigo
          • Vitoria
          • Zaragoza
        • United Kingdom
          • London
        • Portugal
          • Faro
          • Lisboa
        • Italy
          • Milano
          • Roma Casilino
          • Roma Parioli
        • Argentine
          • Buenos Aires
        • Panama
          • Panamá
        • Chile
          • Santiago de Chile
        • Brazil
          • Salvador
        • USA
          • RMA of Florida
          • RMA of New Jersey
          • RMA of Philadelphia
          • RMA of Southern California
  • FAQs
        • Your first visit to IVI
        • How hormones affect your ability to get pregnant
        • What is infertility?
        • Causes of infertility
        • IVI around the world
        • Where Life Begins
        • Quality and continuous improvement
        • COD-19
        • Coronavirus: COVID-19
  • Egg Donation Program in Spain
  • Blog
  • Request information
  • Submenu-item-responsive-2
    • Egg Donation Program in Spain
    • Blog
    • Private area
  • Submenu-item-responsive-3
    • Success rates
    • Prices
    • The team
    • True stories

22 October 2020

IVIRMA presents 74 studies with important findings regarding safety and success of assisted reproduction

Home > Press room > IVIRMA presents 74 studies with important findings regarding safety and success of assisted reproduction
IVIRMA presents 74 studies with important findings regarding safety and success of assisted reproduction

  • The use of nitrogen slush at -210ºC for embryo vitrification could improve embryo survival rate when compared to conventional liquid nitrogen at -196ºC
  • Non-invasive pre-implantation genetic testing for aneuploidy become a starting point for improving results in terms of their reliability as a useful diagnostic tool.

VALENCIA, OCTOBER 22th, 2020

The American Society for Reproductive Medicine (ASRM) 76th Scientific Congress and Expo is underway. It is one of the most important Assisted Reproduction conferences worldwide, where researchers and specialists in the reproductive field gather to share the latest advances in Reproductive Medicine with their colleagues, laying out the future of a specialty that helps so many dreams come true.

On this occasion, and given the global health situation, the meeting will take place online, between October 17th and October 21st. In this forum, IVIRMA presents 74 studies with important achievements in the field in regards to safety and efficacy: “Every year, we share our most exciting findings at the ASRM meeting. These findings result from our commitment to scientific discovery. We are aware that this work will set the path to increase treatment success rates, while we continue to prioritize the safety of our patients. We aim to provide them a reason not only to be hopeful, but also to be confident that they will fulfil their dream of becoming parents”, says Dr. Emre Seli, Chief Scientific Officer at IVIRMA.

Assisted reproduction and safety

Safety has become, now more than ever, a cornerstone for IVIRMA and its clinicians. Thus, this year, many IVIRMA research projects focused on safety and accuracy, with the goal of offering the highest assurances to women and couples who entrust them with their greatest wish.

“One of our studies presented at this year’s ASRM Congress shows how the use of nitrogen slush at -210ºC for embryo vitrification could increase their survival rate. Our researchers have observed that cryopreservation of blastocysts in slush nitrogen allows for improved survival after thawing, owing to the reduction in toxicity associated with vitrification, when compared to conventional liquid nitrogen at -196ºC, which is currently used to preserve gametes and embryos. This offers promise for improved efficiency in cryopreserving embryos for future use and for optimization of in vitro fertilization results”, Dr. Seli explains.

Improving preimplantation genetic testing

In addition, two large studies from IVIRMA studied the accuracy of preimplantation genetic testing: one using trophectoderm biopsy and the other one, a non-invasive approach, by analyzing embryo culture medium.

“It is important to highlight our studies regarding the verification of the information from genomic testing. Currently, preimplantational genetic testing for aneuploidy (PGT-A) is performed by analyzing trophectoderm biopsies. Here we report the validation of a PGT-A platform that we developed, which provides a 100% high accuracy in predicting embryos that will not result in a live birth.”

Our challenge

“In addition, we analyzed the reliability of a non-invasive preimplantational genetic testing for aneuploidy (niPGT-A) platform. Unfortunately, at this time, niPGT-A seems to lack the sufficient precision to be a useful diagnostic tool. Our challenge? To continue to work to fine tune the results of this type of techniques”, Dr. Seli concludes.

Share on social networks

twitter facebook

Share on social networks

twitter facebook

PRESS ROOM CONTACTS

  • Lucía Renau
  • Dori Argente
  • Email: prensa@ivi.es
  • Phone number: (0034) 96 317 36 10
  • Calle Colón, 1 - 46004 (Valencia)

PRESS PACK

Last update
February 2020

Download PDF

Back to toparrow_drop_up
IVI

© 2021 IVI.
All rights reserved

  • Legal Notice
  • Cookies Policy
  • Assisted reproduction treatments
  • Clinics
  • FAQs
  • Corporate information
  • IVI Global Education
  • IVIRMA Innovation
  • Jobs at IVI
  • Press room
  • IVIRMA Media Awards
HEAD OFFICES
  • location_on Calle Colón 1, 4ª planta, 46004 Valencia. España.
  • España
  • Italia
  • Portugal
  • France
  • Deutschland
  • РОССИЯ
  • UK
COUNTRY
International
España Italia Portugal France Deutschland РОССИЯ UK
  • Certificado
  • Certificado
  • Certificado
  • logo
SOCIAL NETWORKS
    • rrss
    • rrss
    • rrss
    • rrss
    • rrss
RECEIVE OUR NEWSLETTER
Sending
Thank you for subscribing!